Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Patel

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
European Radiology|June 2, 2022
Virtual conferences: results of an international survey on radiologist preferences and perspectivesGennaro D'Anna, Lorenzo Ugga, Renato Cuocolo, et al.
Pediatric Research|April 19, 2017
Low birth weight is associated with impaired murine kidney development and functionChristina Barnett, Oluwadara Nnoli, Wasan Abdulmahdi, et al.
Ophthalmology|October 24, 2021
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X StudyRaymond S Douglas, George J Kahaly, Shoaib Ugradar, et al.
The New England Journal of Medicine|January 24, 2020
Teprotumumab for the Treatment of Active Thyroid Eye DiseaseRaymond S Douglas, George J Kahaly, Amy Patel, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
European Radiology|June 2, 2022
Virtual conferences: results of an international survey on radiologist preferences and perspectivesGennaro D'Anna, Lorenzo Ugga, Renato Cuocolo, et al.
Pediatric Research|April 19, 2017
Low birth weight is associated with impaired murine kidney development and functionChristina Barnett, Oluwadara Nnoli, Wasan Abdulmahdi, et al.
Ophthalmology|October 24, 2021
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X StudyRaymond S Douglas, George J Kahaly, Shoaib Ugradar, et al.
The New England Journal of Medicine|January 24, 2020
Teprotumumab for the Treatment of Active Thyroid Eye DiseaseRaymond S Douglas, George J Kahaly, Amy Patel, et al.
Pageof 5